ReviewJournal of kidney cancer and VHL2022

Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma.

Iraklis C Mitsogiannis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.